Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
This trial is active, not recruiting.
|Treatment||administering three additional mri images|
|Sponsor||University of Arkansas|
|Collaborator||Siemens Molecular Imaging|
|Start date||June 2009|
|End date||March 2016|
|Trial size||100 participants|
|Trial identifier||NCT01018927, 110104|
The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.
This study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma.
time frame: The time frame is five additional minutes & three additional images during and MRI.
Male or female participants from 18 years up to 80 years old.
Inclusion Criteria: - All races and ethnic groups - Male and female ages 18-80 years of age - History of multiple myeloma - CMR study for evaluation for cardiac amyloidosis Exclusion Criteria: - Pregnant women - Subject with a metallic or electronic or other device that could be affected by the magnet
|Official title||Role of Cardiac MR (CMR) In Detecting Features of Early Myocardial Infiltration With Amyloid and Light Chain Deposition Disease in Subjects With Multiple Myeloma|
|Principal investigator||Kedar Jambhekar, MD|
|Description||The purpose is to investigate the use of multiple newer CMR techniques for early evaluation of cardiac amyloidosis in multiple myeloma.|
Call for more information